Page last updated: 2024-12-08

canaline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

canaline: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID441443
CHEMBL ID1231652
CHEBI ID41401
SCHEMBL ID440859
MeSH IDM0042333

Synonyms (29)

Synonym
CHEMBL1231652
C08270
canaline
l-canaline ,
DB02821
l-2-amino-4-(aminooxy)butyric acid
(2s)-2-amino-4-aminooxybutanoic acid
AKOS006274866
o-amino-l-homoserine
A827808
(s)-2-amino-4-(aminooxy)butanoic acid
t7h2xp1zns ,
l-homoserine, o-amino-
1-amino-3-amino-oxybutyric acid
unii-t7h2xp1zns
2-amino-4-(aminooxy)butyric acid
SCHEMBL440859
(2s)-2-amino-4-(aminooxy)butanoic acid
DTXSID60197925
l-alpha-amino-gamma-(aminooxy)-n-butyric acid
l-canaline base
FQPGMQABJNQLLF-VKHMYHEASA-N
Q5031083
HY-129476
CS-0105722
CHEBI:41401
.gamma.-(aminooxy)-.alpha.-aminobutyric acid
EN300-128726
(s)-2-amino-4-(aminooxy)butanoicacid

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The results of these studies suggest that the mechanism of L-canavanine toxicity is mediated through L-arginine-utilizing mechanisms and that the L-canavanine metabolite, L-canaline, is toxic to human PBMCs by disrupting polyamine biosynthesis."( The antiproliferative and immunotoxic effects of L-canavanine and L-canaline.
Adams, VR; Bence, AK; Crooks, PA; Worthen, DR, 2002
)
0.74
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antimetaboliteA substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
phytogenic insecticideAn insecticide compound naturally occurring in plants.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
non-proteinogenic L-alpha-amino acidAny L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
canavanine degradation012
canavanine biosynthesis014

Bioassays (1)

Assay IDTitleYearJournalArticle
AID496819Antimicrobial activity against Plasmodium falciparum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (48.39)18.7374
1990's10 (32.26)18.2507
2000's5 (16.13)29.6817
2010's1 (3.23)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.05 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index95.99 (26.88)
Search Engine Supply Index3.20 (0.95)

This Compound (42.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.06%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (93.94%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]